Indication
Exercise-induced bronchospasm prevention
Exercise-induced bronchospasm prevention refers to the prophylactic inhibition of acute, transient airway narrowing triggered by physical exertion. Read more about Exercise-induced bronchospasm prevention
129 drugs 78 manufacturers
Drugs that treat it
Common Exercise-induced bronchospasm prevention therapies.
PROVENTIL HFA (albuterol sulfate)
FORMOTEROL FUMARATE
FORMOTEROL FUMARATE
ALBUTEROL SULFATE HFA (albuterol sulfate)
MONTELUKAST SODIUM
FORMOTEROL FUMARATE
ALBUTEROL SULFATE
MONTELUKAST SODIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonExercise-induced bronchospasm prevention refers to the prophylactic inhibition of acute, transient airway narrowing triggered by physical exertion.
The condition primarily impacts the lower respiratory tract in physically active individuals, occurring both in those with underlying chronic asthma and in otherwise healthy persons.
Pathophysiologically, rapid hyperpnea during exercise leads to excessive thermal and water loss from the airway mucosa, causing mucosal dehydration, hyperosmolarity, and subsequent release of inflammatory mediators that stimulate bronchial smooth muscle contraction.
Prophylactic management aims to suppress this hyperresponsive airway constriction to prevent hallmark symptoms such as wheezing, dyspnea, chest tightness, and sudden declines in post-exercise expiratory airflow.
- nih.gov
Exercise-induced bronchospasm prevention refers to the prophylactic inhibition of acute, transient airway narrowing triggered by physical exertion Prophylactic management aims to suppress this hyperresponsive airway constriction to prevent hallmark symptoms such as wheezing, dyspnea, chest tightness, and sudden declines in post-exercise expiratory airflow
- thoracic.org
Exercise-induced bronchospasm prevention refers to the prophylactic inhibition of acute, transient airway narrowing triggered by physical exertion The condition primarily impacts the lower respiratory tract in physically active individuals, occurring both in those with underlying chronic asthma and in otherwise healthy persons
- aafp.org
The condition primarily impacts the lower respiratory tract in physically active individuals, occurring both in those with underlying chronic asthma and in otherwise healthy persons
- aafp.org
Pathophysiologically, rapid hyperpnea during exercise leads to excessive thermal and water loss from the airway mucosa, causing mucosal dehydration, hyperosmolarity, and subsequent release of inflammatory mediators that stimulate bronchial smooth muscle contraction
- uspharmacist.com
Pathophysiologically, rapid hyperpnea during exercise leads to excessive thermal and water loss from the airway mucosa, causing mucosal dehydration, hyperosmolarity, and subsequent release of inflammatory mediators that stimulate bronchial smooth muscle contraction Prophylactic management aims to suppress this hyperresponsive airway constriction to prevent hallmark symptoms such as wheezing, dyspnea, chest tightness, and sudden declines in post-exercise expiratory airflow
- aaaai.org
Pathophysiologically, rapid hyperpnea during exercise leads to excessive thermal and water loss from the airway mucosa, causing mucosal dehydration, hyperosmolarity, and subsequent release of inflammatory mediators that stimulate bronchial smooth muscle contraction
Personalize your experience
Follow Exercise-induced bronchospasm prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.